JPH06157276A - Skin external preparation - Google Patents

Skin external preparation

Info

Publication number
JPH06157276A
JPH06157276A JP31521292A JP31521292A JPH06157276A JP H06157276 A JPH06157276 A JP H06157276A JP 31521292 A JP31521292 A JP 31521292A JP 31521292 A JP31521292 A JP 31521292A JP H06157276 A JPH06157276 A JP H06157276A
Authority
JP
Japan
Prior art keywords
group
skin
external preparation
carbon atoms
hydrocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP31521292A
Other languages
Japanese (ja)
Other versions
JP2741143B2 (en
Inventor
Atsushi Nakajima
淳 中島
Masataka Fukuda
昌孝 福田
Yukihiro Ohashi
幸浩 大橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP31521292A priority Critical patent/JP2741143B2/en
Publication of JPH06157276A publication Critical patent/JPH06157276A/en
Application granted granted Critical
Publication of JP2741143B2 publication Critical patent/JP2741143B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a skin external preparation containing a specific amine derivative (acid additional salt) and a specific amide derivative, excellent in ability capable of retaining water content of corneum and effect capable of preventing and treating chapped skin and useful for cosmetics, creams, etc. CONSTITUTION:The skin external preparation contains (A) preferably 0.001-2wt.% one or two or kinds of compounds selected from amine derivatives expressed by formula I [R<1> is 4-40C hydrocarbon; R<2> to R<6> are H or 1-10C hydrocarbon; X is O or COO (carbonyl is bound to R<1>)] and its acid additional salt and (B) preferably 0.1-20wt.% one or two or more kinds of compounds expressed by formula II [R<7> is 10-26C hydrocarbon; R<8> is 9-25C hydrocarbon; Y and Z are H or (CH2)nOH [(n) is 1-3]; A is single bond or O-CH2].

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は皮膚外用剤、更に詳しく
は角質層の水分保持能力を高め、肌荒れを予防及び改善
する皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation, and more particularly to a skin external preparation for enhancing the water-retaining ability of the stratum corneum to prevent and improve rough skin.

【0002】[0002]

【従来の技術】一般に、肌にうるおいを与え、柔軟性を
維持するには、角質層中に含まれる水分が重要であるこ
とが知られている。また、当該水分の保持には、角質層
中に含有される水溶性成分、すなわち、遊離アミノ酸、
有機酸、尿素又は無機イオン等が寄与していることも知
られており、従来、これらの水溶性成分を単独で又は組
み合わせて配合した薬用皮膚外用剤や化粧料が肌荒れの
改善又は予防の目的で使用されている。
2. Description of the Related Art Generally, it is known that the water content in the stratum corneum is important in order to moisturize the skin and maintain flexibility. Further, in order to retain the water, a water-soluble component contained in the stratum corneum, that is, free amino acid,
It is also known that organic acids, urea, inorganic ions, etc. contribute, and conventionally, a medicated external preparation for skin or a cosmetic containing these water-soluble components alone or in combination is used for the purpose of improving or preventing rough skin. Used in.

【0003】また、これらの角質層中に含まれる水溶性
成分とは別に、水との親和性の高い様々な保湿性物質が
開発されており、同様の目的で使用されている。
In addition to the water-soluble components contained in the stratum corneum, various moisturizing substances having a high affinity with water have been developed and used for the same purpose.

【0004】しかしながら、従来の水溶性成分や保湿性
物質を皮膚に適用した場合、その作用は皮膚角質上にあ
って水分を角質に供給するというもので、その効果は一
時的であり、根本的に角質層の水分保持能力を改善し、
肌荒れを本質的に予防又は治癒させるというものではな
かった。
However, when a conventional water-soluble component or moisturizing substance is applied to the skin, its effect is that it exists on the skin keratin and supplies water to the keratin, and its effect is temporary and fundamental. To improve the water retention capacity of the stratum corneum,
It did not essentially prevent or heal skin irritation.

【0005】[0005]

【発明が解決しようとする課題】従って、根本的に角質
層の水分保持能力を改善し、肌荒れを本質的に予防及び
治癒し得る皮膚外用剤の開発が望まれていた。
Therefore, there has been a demand for the development of an external preparation for the skin which can fundamentally improve the water-retaining ability of the stratum corneum and essentially prevent and cure rough skin.

【0006】[0006]

【課題を解決するための手段】そこで、本出願人は角質
層の水分保持能力を根本的に改善する化合物を求めるべ
く検討してきたところ、下記の一般式(2′)
Therefore, the present applicant has been investigating to find a compound that fundamentally improves the water-retaining ability of the stratum corneum, and the following general formula (2 ')

【0007】[0007]

【化3】 [Chemical 3]

【0008】〔式中、R9 は炭素数10〜26の直鎖又
は分岐鎖の飽和又は不飽和の炭化水素基を示し、R10
炭素数9〜25の直鎖又は分岐鎖の飽和又は不飽和の炭
化水素基を示す〕で表わされるアミド誘導体を保湿剤と
して用いれば角質層の水分保持能力を改善できることを
見出し、先に出願した(特許第1557842号)。
[0008] wherein, R 9 represents a linear or branched, saturated or unsaturated hydrocarbon group of 10-26 carbon atoms, R 10 is a saturated or a straight-chain or branched-chain 9 to 25 carbon atoms It was found that the water retention ability of the stratum corneum can be improved by using an amide derivative represented by [showing an unsaturated hydrocarbon group] as a moisturizing agent, and filed previously (Patent No. 1557842).

【0009】しかし、近年更なる肌荒れ改善効果の向上
が望まれており、本発明者らは種々の化合物について検
討を行ったところ、後記一般式(1)で表わされるアミ
ン誘導体又はその酸付加塩と後記一般式(2)で表わさ
れるアミド誘導体とを組み合わせて用いれば、更に角質
層の水分保持能力を向上し、極めて優れた肌荒れの予防
及び改善効果を有する皮膚外用剤が得られることを見出
し、本発明を完成した。
However, in recent years, it has been desired to further improve the rough skin improving effect, and the present inventors have studied various compounds. As a result, the amine derivative represented by the following general formula (1) or its acid addition salt is shown. It has been found that, when used in combination with an amide derivative represented by the general formula (2) described below, a skin external preparation that further improves the water retention capacity of the stratum corneum and has an extremely excellent effect of preventing and improving rough skin is obtained. The present invention has been completed.

【0010】すなわち、本発明は次の成分(A)及び
(B) (A)次の一般式(1)
That is, the present invention comprises the following components (A) and (B) (A) the following general formula (1)

【0011】[0011]

【化4】 [Chemical 4]

【0012】〔式中、R1 は水酸基で置換されていても
よい炭素数4〜40の直鎖、分岐鎖又は環状の炭化水素
基を示し、R2、R3、R4、R5 及びR6 はそれぞれ水
素原子又は1若しくは2以上の水酸基で置換されていて
もよい炭素数1〜10の炭化水素基を示し、Xは−O−
又は−CO−O−(但し、カルボニル基はR1 と結合す
る)を示す〕で表わされるアミン誘導体及びその酸付加
塩から選ばれる一種又は二種以上 (B)次の一般式(2)
[In the formula, R 1 represents a linear, branched or cyclic hydrocarbon group having 4 to 40 carbon atoms which may be substituted with a hydroxyl group, and R 2 , R 3 , R 4 , R 5 and R 6 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms which may be substituted with one or more hydroxyl groups, and X represents —O—
Or one or more selected from an amine derivative represented by —CO—O— (wherein a carbonyl group is bonded to R 1 ) and an acid addition salt thereof (B) the following general formula (2)

【0013】[0013]

【化5】 [Chemical 5]

【0014】〔式中、R7 は炭素数10〜26の直鎖又
は分岐鎖の飽和又は不飽和の炭化水素基を示し、R8
炭素数9〜25の直鎖又は分岐鎖の飽和又は不飽和の炭
化水素基を示し、Y及びZはそれぞれ水素原子又は−
(CH2n−OH(ここでnは1〜3の数を示す)を示
し、Aは単結合又は−O−CH2−(但し、酸素原子は
3と結合する)を示す〕で表わされるアミド誘導体か
ら選ばれる一種又は二種以上を含有することを特徴とす
る皮膚外用剤を提供するものである。
[In the formula, R 7 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and R 8 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms. Represents an unsaturated hydrocarbon group, and Y and Z are each a hydrogen atom or-
(CH 2 ) n —OH (where n represents a number of 1 to 3), A represents a single bond or —O—CH 2 — (where an oxygen atom is bonded to R 3 )]. The present invention provides a skin external preparation characterized by containing one or more selected from the represented amide derivatives.

【0015】本発明に用いられる(A)成分である一般
式(1)で表わされるアミン誘導体において、R1 は水
酸基で置換されていてもよい炭素数4〜40の直鎖、分
岐鎖又は環状の飽和又は不飽和の炭化水素基を示すが、
その具体例としては、ブチル基、ヘキシル基、オクチル
基、デシル基、ドデシル基、テトラデシル基、ペンタデ
シル基、ヘキサデシル基、オクタデシル基、ドコシル
基、ドトリアコンチル基、メチル分岐イソステアリル
基、2−エチルヘキシル基、2−ヘプチルウンデシル
基、5,7,7−トリメチル−2−(1,3,3−トリ
メチルブチル)−オクチル基等のアルキル基;9−オク
タデセニル、9,12−オクタデカジエニル基等のアル
ケニル基;シクロヘキシル基等の脂環式炭化水素基;フ
ェニル基、ベンジル基等の芳香族炭化水素基;コレステ
リル基等の炭化水素基が挙げられる。また、R2、R3
4、R5 及びR6 はそれぞれ水素原子又は1若しくは
2以上の水酸基で置換されていてもよい炭素数1〜10
の炭化水素基を示すが、その具体例としては、水素原子
及びメチル基、エチル基、ブチル基、ヘキシル基、フェ
ニル基、ベンジル基、ヒドロキシメチル基、ヒドロキシ
エチル基、1,2−ジヒドロキシエチル基、1,2,3
−トリヒドロキシプロピル基、1,2,3,4−テトラ
ヒドロキシブチル基、1,2,3,4,5−ペンタヒド
ロキシペンチル基等の炭化水素基が挙げられる。また、
Xは−O−又は−CO−O−(但し、カルボニル基はR
1 と結合する)を示す。
In the amine derivative represented by the general formula (1) which is the component (A) used in the present invention, R 1 is a straight chain, branched chain or cyclic group having 4 to 40 carbon atoms which may be substituted with a hydroxyl group. Shows a saturated or unsaturated hydrocarbon group of
Specific examples thereof include butyl group, hexyl group, octyl group, decyl group, dodecyl group, tetradecyl group, pentadecyl group, hexadecyl group, octadecyl group, docosyl group, dotriacontyl group, methyl-branched isostearyl group, 2-ethylhexyl group, Alkyl groups such as 2-heptylundecyl group and 5,7,7-trimethyl-2- (1,3,3-trimethylbutyl) -octyl group; 9-octadecenyl, 9,12-octadecadienyl group and the like Examples thereof include alkenyl groups; alicyclic hydrocarbon groups such as cyclohexyl groups; aromatic hydrocarbon groups such as phenyl groups and benzyl groups; and hydrocarbon groups such as cholesteryl groups. In addition, R 2 , R 3 ,
R 4 , R 5 and R 6 are each a hydrogen atom or have 1 to 10 carbon atoms which may be substituted with one or more hydroxyl groups.
The specific examples of the hydrocarbon groups are hydrogen atom and methyl group, ethyl group, butyl group, hexyl group, phenyl group, benzyl group, hydroxymethyl group, hydroxyethyl group, 1,2-dihydroxyethyl group. , 1, 2, 3
And hydrocarbon groups such as trihydroxypropyl group, 1,2,3,4-tetrahydroxybutyl group, 1,2,3,4,5-pentahydroxypentyl group. Also,
X is -O- or -CO-O- (provided that the carbonyl group is R
Combined with 1 ).

【0016】かかる本発明におけるアミン誘導体(1)
のうち、Xが−O−であり、かつR 2、R3、R4、R5
及びR6 が水素原子であるものは、そのN−アシル体で
あるアミド誘導体〔前記一般式(2′)〕の製造中間体
として公知の化合物である(特開昭62−228048
号公報)。しかし、それ自身の皮膚に対する作用につい
ては全く知られていなかった。
The amine derivative (1) in the present invention
Of these, X is -O-, and R 2, R3, RFour, RFive
And R6Is an N-acyl derivative of
Intermediate for production of certain amide derivative [the above general formula (2 ')]
Known as (JP-A-62-228048).
Issue). However, regarding its own effects on the skin,
Was not known at all.

【0017】本発明に使用されるアミン誘導体(1)
は、公知の種々の方法により合成される。例えば、下記
反応式に従って、グリシジルエーテル又はエステル誘導
体(3)にアミン誘導体(4)を付加させることにより
合成される。
Amine derivative (1) used in the present invention
Is synthesized by various known methods. For example, it is synthesized by adding the amine derivative (4) to the glycidyl ether or ester derivative (3) according to the following reaction formula.

【0018】[0018]

【化6】 [Chemical 6]

【0019】〔式中、R1、R2、R3、R4、R5、R6
及びXは前記と同じ意味を有する〕
[Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6
And X have the same meaning as above]

【0020】このようにして得られるアミン誘導体
(1)は、更に、必要に応じて、常法により塩酸、硫
酸、硝酸、リン酸等の無機酸塩又はコハク酸、フマル
酸、ヘキサデカン酸、オクタデカン酸、乳酸、グリコー
ル酸、クエン酸、酒石酸、安息香酸等の有機酸塩とする
ことができる。
The amine derivative (1) thus obtained is further subjected, if necessary, to an inorganic acid salt such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid or the like, or succinic acid, fumaric acid, hexadecanoic acid, octadecane, according to a conventional method. It may be an organic acid salt such as acid, lactic acid, glycolic acid, citric acid, tartaric acid or benzoic acid.

【0021】本発明において(A)成分のアミン誘導体
及びその酸付加塩は一種を単独で、又は二種以上を組み
合わせて用いることができ、その配合量は特に制限され
ないが、全組成中に0.0001〜10重量%(以下、
単に%で示す)、特に0.001〜2%が好ましい。配
合量が0.0001%未満では本発明の効果が充分達成
されず、10%を超えてもそれ以上の効果の向上は認め
られない。
In the present invention, the amine derivative as the component (A) and the acid addition salt thereof can be used alone or in combination of two or more, and the compounding amount is not particularly limited, but is 0 in the whole composition. 0.0001 to 10% by weight (hereinafter,
(Only shown in%), particularly 0.001 to 2% is preferable. If the blending amount is less than 0.0001%, the effect of the present invention is not sufficiently achieved, and if it exceeds 10%, further improvement of the effect is not recognized.

【0022】また、本発明に用いられる(B)成分であ
る一般式(2)で表わされるアミド誘導体において、R
7 は炭素数10〜26の直鎖又は分岐鎖の飽和又は不飽
和の炭化水素基を示すが、その具体例としては、デシル
基、ウンデシル基、ドデシル基、トリデシル基、テトラ
デシル基、ペンタデシル基、ヘキサデシル基、オクタデ
シル基、エイコシル基、ドコシル基、テトラコシル基、
ペンタコシル基、ヘキサコシル基、2−エチルオクチル
基、3−エチルオクチル基等のアルキル基;オレイル
基、リノレイル基等のアルケニル基;アントラセニル基
等の脂環式炭化水素基;ジフェニルメチル基、ナフチル
基等の芳香族炭化水素基が挙げられる。また、一般式
(2)中、R8 は炭素数9〜25の直鎖又は分岐鎖の飽
和又は不飽和の炭化水素基を示すが、その具体例として
は、ノニル基、2−メチルオクチル基等のアルキル基;
メシチル基等の芳香族炭化水素基;及び前記の炭化水素
基のうち、炭素数25までのものが挙げられる。
Further, in the amide derivative represented by the general formula (2) which is the component (B) used in the present invention, R
7 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and specific examples thereof include a decyl group, an undecyl group, a dodecyl group, a tridecyl group, a tetradecyl group, a pentadecyl group, Hexadecyl group, octadecyl group, eicosyl group, docosyl group, tetracosyl group,
Alkyl groups such as pentacosyl group, hexacosyl group, 2-ethyloctyl group, 3-ethyloctyl group; alkenyl groups such as oleyl group, linoleyl group; alicyclic hydrocarbon groups such as anthracenyl group; diphenylmethyl group, naphthyl group, etc. The aromatic hydrocarbon group of Further, in the general formula (2), R 8 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms, and specific examples thereof include a nonyl group and a 2-methyloctyl group. Alkyl groups such as;
An aromatic hydrocarbon group such as a mesityl group; and those having 25 carbon atoms among the above hydrocarbon groups.

【0023】かかるアミド誘導体(2)は、公知の方法
〔例えば、ポリッシュ・ジャーナル・オブ・ケミストリ
ー(Pol.J.Chem.)52,1059(197
8);同52,1283(1978);特開昭54−1
17421号、同54−144308号、同54−14
7937号公報〕に準じて製造することができる。すな
わち、次に示される反応式に従って、グリシジルエーテ
ル(5)とアルカノールアミン(6)から得られる化合
物(7)をアシル化し、次いでエステル基を選択的に加
水分解することによって製造することができる。
The amide derivative (2) can be prepared by a known method [for example, Polish Journal of Chemistry (Pol. J. Chem.) 52 , 1059 (197).
8); ibid. 52 , 1283 (1978); JP-A-54-1.
No. 17421, No. 54-144308, No. 54-14
7937 gazette]. That is, it can be produced by acylating the compound (7) obtained from the glycidyl ether (5) and the alkanolamine (6) according to the reaction formula shown below, and then selectively hydrolyzing the ester group.

【0024】[0024]

【化7】 [Chemical 7]

【0025】〔式中、R7、R8、Y及びZは前記と同じ
意味を有し、Z′はZが−(CH2n−OHの場合はZ
から水素原子を除いたアニオン基を示し、Zが水素原子
の場合は単結合を示す〕
[Wherein R 7 , R 8 , Y and Z have the same meanings as described above, and Z'is Z when Z is-(CH 2 ) n -OH.
Represents an anion group excluding a hydrogen atom, and represents a single bond when Z is a hydrogen atom.]

【0026】かかるアミド誘導体のうち特に好ましいも
のとしては次の一般式(2−a)及び一般式(2−b)
で表わされるものである。
Among these amide derivatives, particularly preferable are the following general formulas (2-a) and (2-b).
Is represented by.

【0027】[0027]

【化8】 [Chemical 8]

【0028】〔式中、R7 及びR8 は前記と同じ意味を
有する〕本発明において(B)成分のアミド誘導体は一
種を単独で、又は二種以上を組み合わせて用いることが
でき、その配合量は特に制限されないが、全組成中に
0.001〜50%、特に0.1〜20%が好ましい。
配合量が0.01%未満では本発明の効果が充分達成さ
れず、20%を超えてもそれ以上の効果の向上は認めら
れない。
[In the formula, R 7 and R 8 have the same meanings as described above.] In the present invention, the amide derivative of the component (B) can be used alone or in combination of two or more, and the combination thereof. The amount is not particularly limited, but 0.001 to 50%, particularly 0.1 to 20% is preferable in the entire composition.
If the blending amount is less than 0.01%, the effect of the present invention is not sufficiently achieved, and if it exceeds 20%, further improvement of the effect is not observed.

【0029】本発明の皮膚外用剤はその使用形態によ
り、薬用皮膚外用剤と化粧料に大別される。
The skin external preparation of the present invention is roughly classified into a medicated skin external preparation and a cosmetic, depending on its use form.

【0030】薬用皮膚外用剤としては、例えば薬効成分
を含有する各種軟膏剤を挙げることができる。ここで、
軟膏剤としては、油性基剤をベースとするもの、油/
水、水/油型の乳化系基剤をベースとするもののいずれ
であってもよい。また、油性基剤としては、特に制限は
なく、例えば植物油、動物油、合成油、脂肪酸及び天然
又は合成のグリセライド等が挙げられる。更に、薬効成
分としては、特に制限はなく、例えば鎮痛消炎剤、鎮痒
剤、殺菌消毒剤、収斂剤、皮膚軟化剤、ホルモン剤等を
必要に応じて適宜使用することができる。
Examples of the external medicated skin preparation include various ointments containing medicinal components. here,
As an ointment, those based on an oily base, oil /
It may be based on water or a water / oil type emulsion base. The oily base is not particularly limited, and examples thereof include vegetable oil, animal oil, synthetic oil, fatty acid and natural or synthetic glyceride. Further, the medicinal component is not particularly limited, and for example, an analgesic / anti-inflammatory agent, an antipruritic agent, a bactericidal disinfectant, an astringent agent, an emollient agent, a hormone agent and the like can be appropriately used as necessary.

【0031】また、化粧料としては、種々の形態、例え
ば水/油、油/水型乳化化粧料、クリーム、化粧乳液、
化粧水、油性化粧料、パック剤、口紅、ファウンデーシ
ョン、皮膚洗浄剤、ヘアートニック、整髪剤、養毛剤、
育毛剤等の皮膚化粧料とすることができる。
As the cosmetics, various forms such as water / oil, oil / water emulsion cosmetics, creams, cosmetic emulsions,
Lotion, oily cosmetic, pack, lipstick, foundation, skin cleanser, hair tonic, hair styling agent, hair nourishing agent,
It can be a skin cosmetic such as a hair restorer.

【0032】本発明の皮膚外用剤を化粧料として使用す
る場合、必須成分の他に化粧料成分として一般に使用さ
れている油分、保湿剤、紫外線吸収剤、アルコール類、
キレート剤、pH調整剤、防腐剤、増粘剤、色素、香料等
を任意に組み合わせて配合することができる。
When the external preparation for skin of the present invention is used as a cosmetic, in addition to the essential ingredients, oils, moisturizers, UV absorbers, alcohols, which are generally used as cosmetic ingredients,
A chelating agent, a pH adjuster, an antiseptic, a thickener, a dye, a fragrance and the like can be optionally combined and blended.

【0033】本発明の皮膚外用剤は、上述の必須成分で
ある(A)成分及び(B)成分並びに他の油相成分を加
温して溶解したものに、必要に応じて水相成分を加えて
混合することにより製造するのが好ましい。
The external preparation for skin of the present invention is obtained by heating and dissolving the above-mentioned essential components (A) and (B) and other oil phase components, and optionally adding an aqueous phase component. In addition, it is preferable to manufacture by mixing.

【0034】[0034]

【発明の効果】本発明の皮膚外用剤は、(A)成分のア
ミン誘導体又はその酸付加塩と(B)成分のアミド誘導
体とを併用することにより、相乗的な角質水分保持能力
の向上効果を奏し、極めて優れた肌荒れの予防及び治癒
効果を有するものである。
INDUSTRIAL APPLICABILITY The external preparation for skin of the present invention uses the amine derivative or its acid addition salt of the component (A) in combination with the amide derivative of the component (B) to synergistically improve the keratin water retention ability. It has an excellent effect of preventing and healing rough skin.

【0035】[0035]

【実施例】以下に実施例を挙げて本発明を具体的に説明
するが、本発明はこれらによって何ら限定されるもので
はない。尚、本実施例における肌荒れ改善効果について
の評価方法を以下に示す。
EXAMPLES The present invention will be described in detail below with reference to examples, but the present invention is not limited thereto. The evaluation method for the rough skin improving effect in this example is shown below.

【0036】(試験方法)冬期に頬部に肌荒れを起こし
ている20〜50才の女性10名を被験者とし、左右の
頬に異なる皮膚外用剤を2週間塗布する。2週間の塗布
が終了した翌日に、次の項目につき試験を行った。 (1)皮膚コンダクタンス 37℃の温水にて洗顔後、温度20℃、湿度40%の部
屋で20分間安静にした後、角質層の水分含有量を皮膚
コンダクタンスメーター(IBS社製)にて測定した。
皮膚コンダクタンス値は値が小さいほど肌荒れが生じて
いて、5以下ではひどい肌荒れが生じていることを示
す。一方、皮膚コンダクタンス値が20以上であれば、
肌荒れはほとんど生じていない。 (2)肌荒れスコア 肌荒れを肉眼で観察し、下記表1に示す基準により判定
した。スコアは平均値±標準偏差で示した。
(Test Method) Ten females aged 20 to 50 who have rough skin on the cheeks in winter are used as test subjects, and different skin external preparations are applied to the left and right cheeks for 2 weeks. On the day after the application for two weeks was completed, the following items were tested. (1) Skin conductance After washing the face with warm water of 37 ° C. and resting in a room at a temperature of 20 ° C. and a humidity of 40% for 20 minutes, the water content of the stratum corneum was measured with a skin conductance meter (IBS). .
The skin conductance value shows that the smaller the value, the rougher the skin is, and when the value is 5 or less, the rougher the skin is. On the other hand, if the skin conductance value is 20 or more,
Almost no rough skin has occurred. (2) Rough skin score Rough skin was visually observed and judged according to the criteria shown in Table 1 below. The score was shown by the average value +/- standard deviation.

【0037】[0037]

【表1】 [Table 1]

【0038】実施例1 次に示す組成のW/O型クリームを調製し、それぞれに
ついて連続塗布による肌荒れ改善効果の評価を行った。
使用したアミン誘導体の構造と配合量を表3に示し、ア
ミド誘導体の構造と配合量を表4に示し、肌荒れ改善効
果の評価結果を表5に示す。
Example 1 W / O type creams having the compositions shown below were prepared, and the effect of improving skin roughness by continuous application was evaluated for each of them.
The structure and blending amount of the amine derivative used are shown in Table 3, the structure and blending amount of the amide derivative are shown in Table 4, and the evaluation results of the rough skin improving effect are shown in Table 5.

【0039】[0039]

【表2】 (組成) (%) (1)アミン誘導体(表3) 表3 (2)アミド誘導体(表4) 表4 (3)コレステロール 0.5 (4)コレステリルイソステアレート 1.0 (5)ポリエーテル変性シリコーン*1 1.5 (6)環状シリコーン*2 20.0 (7)メチルフェニルポリシロキサン*3 2.0 (8)メチルポリシロキサン*4 2.0 (9)硫酸マグネシウム 0.5 (10)55%エタノール 5.0 (11)精製水 残量 (12)防腐剤 適量 (13)香料 適量(Table 2) (Composition) (%) (1) Amine derivative (Table 3) Table 3 (2) Amide derivative (Table 4) Table 4 (3) Cholesterol 0.5 (4) Cholesteryl isostearate 1.0 ( 5) Polyether-modified silicone * 1 1.5 (6) Cyclic silicone * 2 20.0 (7) Methylphenylpolysiloxane * 3 2.0 (8) Methylpolysiloxane * 4 2.0 (9) Magnesium sulfate 0 .5 (10) 55% ethanol 5.0 (11) Purified water Remaining amount (12) Preservative proper amount (13) Perfume proper amount

【0040】 *1:シリコーンKF−6015,信越化学工業(株)
製 *2:シリコーンSH−244、SH−245又はSH
−244とSH−245の3:2(重量比)混合物,東
レダウコーニング・シリコーン(株)製 *3:シリコーンSF−557,東レダウコーニング・
シリコーン(株)製 *4:シリコーンKF−96A(6cs),信越化学工業
(株)製
* 1: Silicone KF-6015, Shin-Etsu Chemical Co., Ltd.
Made * 2: Silicone SH-244, SH-245 or SH
-244 and SH-245 3: 2 (weight ratio) mixture, manufactured by Toray Dow Corning Silicone Co., Ltd. * 3: Silicone SF-557, Toray Dow Corning
Silicone Co., Ltd. * 4: Silicone KF-96A (6cs), Shin-Etsu Chemical Co., Ltd.

【0041】(製法)油相成分〔(1)〜(5)、
(7)、(8)〕を80℃で加熱溶解したものに、攪拌
しながら80℃に加熱した水相成分〔(9)、(1
1)、(12)〕を加えて乳化した後、50℃まで攪拌
冷却後、(6)、(10)、(13)を加え、更に攪拌
しながら室温まで冷却し、W/Oクリームを調製した。
(Production method) Oil phase component [(1) to (5),
(7), (8)] heated and dissolved at 80 ° C., and an aqueous phase component [(9), (1
1) and (12)] are added and emulsified, and after stirring and cooling to 50 ° C., (6), (10) and (13) are added, and the mixture is further cooled to room temperature with stirring to prepare a W / O cream. did.

【0042】[0042]

【表3】 [Table 3]

【0043】[0043]

【表4】 [Table 4]

【0044】[0044]

【表5】 [Table 5]

【0045】実施例2 以下に示す組成のO/Wクリームを調製した。これは角
質層の水分保持能力を改善し、肌荒れを予防及び治癒す
る効果に優れるものであった。
Example 2 An O / W cream having the following composition was prepared. This improved the water retention capacity of the stratum corneum and was excellent in the effect of preventing and healing rough skin.

【0046】[0046]

【表6】 (組成) (%) (1)ポリオキシエチレン(10)硬化ヒマシ油 1.0 (2)モノステアリン酸ソルビタン 0.5 (3)ステアロイルメチルタウリンナトリウム 0.5 (4)セトステアリルアルコール 2.0 (5)ステアリン酸 1.8 (6)アミン誘導体*5 0.3 (7)アミド誘導体*6 3.0 (8)コレステロール 1.5 (9)コレステリルイソステアレート 1.0 (10)ジカプリン酸ネオペンチルグリコール 8.0 (11)メチルポリシロキサン*7 5.0 (12)グリセリン 5.0 (13)1,3−ブチレングリコール 3.0 (14)防腐剤 適量 (15)精製水 残量 (16)香料 適量(Table 6) (Composition) (%) (1) Polyoxyethylene (10) hydrogenated castor oil 1.0 (2) sorbitan monostearate 0.5 (3) sodium stearoylmethyl taurine 0.5 (4) cetostearyl Alcohol 2.0 (5) Stearic acid 1.8 (6) Amine derivative * 5 0.3 (7) Amide derivative * 6 3.0 (8) Cholesterol 1.5 (9) Cholesteryl isostearate 1.0 ( 10) Neopentyl glycol dicaprate 8.0 (11) Methylpolysiloxane * 7 5.0 (12) Glycerin 5.0 (13) 1,3-Butylene glycol 3.0 (14) Preservative A suitable amount (15) Purification Remaining amount of water (16) Perfume proper amount

【0047】[0047]

【化9】 [Chemical 9]

【0048】(製法)油相成分〔(1)〜(11)〕を
80℃で加熱溶解したものに、攪拌しながら80℃に加
熱した水相成分〔(12)〜(15)〕を加えて乳化し
た後、50℃まで攪拌冷却し、次いで(16)を加え、
更に攪拌しながら室温まで冷却し、O/Wクリームを調
製した。
(Manufacturing method) To an oil phase component [(1) to (11)] heated and dissolved at 80 ° C, an aqueous phase component [(12) to (15)] heated to 80 ° C with stirring was added. After emulsifying, stir and cool to 50 ° C, then add (16),
The mixture was further cooled to room temperature with stirring to prepare an O / W cream.

【0049】実施例3 以下に示す組成の軟膏を調製した。これは角質層の水分
保持能力を改善し、肌荒れを予防及び治癒する効果に優
れるものであった。
Example 3 An ointment having the following composition was prepared. This improved the water retention capacity of the stratum corneum and was excellent in the effect of preventing and healing rough skin.

【0050】[0050]

【表7】 (組成) (%) (1)アミン誘導体*8 1.0 (2)アミド誘導体*9 6.0 (3)白色ワセリン 残量 (4)コレステリルイソステアレート 3.0 (5)流動パラフィン 10.0 (6)グリセリルエーテル*10 1.0 (7)グリセリン 10.0[Table 7] (Composition) (%) (1) Amine derivative * 8 1.0 (2) Amide derivative * 9 6.0 (3) White petrolatum remaining (4) Cholesteryl isostearate 3.0 (5) Liquid paraffin 10.0 (6) Glyceryl ether * 10 1.0 (7) Glycerin 10.0

【0051】[0051]

【化10】 [Chemical 10]

【0052】(製法)(1)〜(7)を加温して溶解し
た後、冷却して軟膏を調製した。
(Production method) (1) to (7) were heated and dissolved, and then cooled to prepare an ointment.

【0053】実施例4 以下に示す組成のO/Wクリームを調製した。これは角
質層の水分保持能力を改善し、肌荒れを予防及び治癒す
る効果に優れるものであった。
Example 4 An O / W cream having the following composition was prepared. This improved the water retention capacity of the stratum corneum and was excellent in the effect of preventing and healing rough skin.

【0054】[0054]

【表8】 (組成) (%) (1)ポリオキシエチレン(10)硬化ヒマシ油 1.0 (2)モノステアリン酸ソルビタン 0.5 (3)ステアロイルメチルタウリンナトリウム 0.5 (4)セトステアリルアルコール 2.0 (5)ステアリン酸 1.8 (6)アミン誘導体*11 0.3 (7)アミド誘導体*12 3.0 (8)コレステロール 1.5 (9)コレステリルイソステアレート 1.0 (10)ジカプリン酸ネオペンチルグリコール 8.0 (11)メチルポリシロキサン*13 5.0 (12)グリセリン 5.0 (13)1,3−ブチレングリコール 3.0 (14)防腐剤 適量 (15)精製水 残量 (16)香料 適量[Table 8] (Composition) (%) (1) Polyoxyethylene (10) hydrogenated castor oil 1.0 (2) sorbitan monostearate 0.5 (3) sodium stearoylmethyl taurine 0.5 (4) cetostearyl Alcohol 2.0 (5) Stearic acid 1.8 (6) Amine derivative * 11 0.3 (7) Amide derivative * 12 3.0 (8) Cholesterol 1.5 (9) Cholesteryl isostearate 1.0 ( 10) Neopentyl glycol dicaprate 8.0 (11) Methyl polysiloxane * 13 5.0 (12) Glycerin 5.0 (13) 1,3-Butylene glycol 3.0 (14) Preservatives Amount (15) Purification Remaining amount of water (16) Perfume proper amount

【0055】[0055]

【化11】 [Chemical 11]

【0056】(製法)油相成分〔(1)〜(11)〕を
80℃で加熱溶解したものに、攪拌しながら80℃に加
熱した水相成分〔(12)〜(15)〕を加えて乳化し
た後、50℃まで攪拌冷却し、次いで(16)を加え、
更に攪拌しながら室温まで冷却し、O/Wクリームを調
製した。
(Manufacturing method) To an oil phase component [(1) to (11)] heated and dissolved at 80 ° C, an aqueous phase component [(12) to (15)] heated to 80 ° C with stirring was added. After emulsifying, stir and cool to 50 ° C, then add (16),
The mixture was further cooled to room temperature with stirring to prepare an O / W cream.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 次の成分(A)及び(B) (A)次の一般式(1) 【化1】 〔式中、R1 は水酸基で置換されていてもよい炭素数4
〜40の直鎖、分岐鎖又は環状の炭化水素基を示し、R
2、R3、R4、R5 及びR6 はそれぞれ水素原子又は1
若しくは2以上の水酸基で置換されていてもよい炭素数
1〜10の炭化水素基を示し、Xは−O−又は−CO−
O−(但し、カルボニル基はR1 と結合する)を示す〕
で表わされるアミン誘導体及びその酸付加塩から選ばれ
る一種又は二種以上 (B)次の一般式(2) 【化2】 〔式中、R7 は炭素数10〜26の直鎖又は分岐鎖の飽
和又は不飽和の炭化水素基を示し、R8 は炭素数9〜2
5の直鎖又は分岐鎖の飽和又は不飽和の炭化水素基を示
し、Y及びZはそれぞれ水素原子又は−(CH2n−O
H(ここでnは1〜3の数を示す)を示し、Aは単結合
又は−O−CH2−(但し、酸素原子はR3と結合する)
を示す〕で表わされるアミド誘導体から選ばれる一種又
は二種以上を含有することを特徴とする皮膚外用剤。
1. The following components (A) and (B) (A) having the following general formula (1): [In the formula, R 1 has 4 carbon atoms which may be substituted with a hydroxyl group.
To 40 linear, branched or cyclic hydrocarbon groups, R
2 , R 3 , R 4 , R 5 and R 6 are each a hydrogen atom or 1
Alternatively, it represents a hydrocarbon group having 1 to 10 carbon atoms which may be substituted with two or more hydroxyl groups, and X is -O- or -CO-.
O- (provided that the carbonyl group is bonded to R 1 )]
One or more selected from amine derivatives and acid addition salts thereof represented by (B) the following general formula (2): [In the formula, R 7 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and R 8 represents 9 to 2 carbon atoms.
5 represents a linear or branched, saturated or unsaturated hydrocarbon group, Y and Z are each a hydrogen atom or a - (CH 2) n -O
H (where n is a number of 1 to 3) indicates, A represents a single bond or -O-CH 2 - (provided that the oxygen atom binds to R 3)
The external preparation for skin comprising one or more selected from amide derivatives represented by
JP31521292A 1992-11-25 1992-11-25 External preparation for skin Expired - Lifetime JP2741143B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP31521292A JP2741143B2 (en) 1992-11-25 1992-11-25 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31521292A JP2741143B2 (en) 1992-11-25 1992-11-25 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH06157276A true JPH06157276A (en) 1994-06-03
JP2741143B2 JP2741143B2 (en) 1998-04-15

Family

ID=18062753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31521292A Expired - Lifetime JP2741143B2 (en) 1992-11-25 1992-11-25 External preparation for skin

Country Status (1)

Country Link
JP (1) JP2741143B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09165313A (en) * 1995-12-15 1997-06-24 Kao Corp Skin preparation for external use
WO2014002837A1 (en) 2012-06-28 2014-01-03 日油株式会社 Volatile oil for cosmetics
JP2014189542A (en) * 2013-03-28 2014-10-06 Kao Corp Method for producing amide derivative

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09165313A (en) * 1995-12-15 1997-06-24 Kao Corp Skin preparation for external use
WO2014002837A1 (en) 2012-06-28 2014-01-03 日油株式会社 Volatile oil for cosmetics
US9855201B2 (en) 2012-06-28 2018-01-02 Nof Corporation Volatile oil for cosmetics
JP2014189542A (en) * 2013-03-28 2014-10-06 Kao Corp Method for producing amide derivative

Also Published As

Publication number Publication date
JP2741143B2 (en) 1998-04-15

Similar Documents

Publication Publication Date Title
JPH0459285B2 (en)
US5759558A (en) Skin care composition
JP2740148B2 (en) Cosmetic or dermatological compositions containing a mixture of ceramides and their use for moisturizing the skin
EP0660720A1 (en) Skin-conditioning composition, its application and manufacture
JPH0657651B2 (en) Cosmetic composition
JPS63192704A (en) Cosmetic
JPS5826726B2 (en) Keshiyouriyo
JPS6115809A (en) Cell activator
JP2741143B2 (en) External preparation for skin
US6017548A (en) Skin care composition
JP3503834B2 (en) Cosmetics
JPS62120308A (en) Cosmetic
JPS60184005A (en) Cosmetic for preventing aging of skin
JP4112741B2 (en) Moisturizer
JP3660374B2 (en) Topical skin preparation
JPH05213731A (en) Skin external agent
JP4188150B2 (en) Skin preparation
JP2003183148A (en) Skin care composition for external use
JPS617205A (en) Cell activator
JP2005002020A (en) Oil-in-water type emulsion cosmetic
JP3522794B2 (en) External preparation for skin
JPH0714846B2 (en) Cosmetics
JPH08231565A (en) Phosphoric acid triester and cosmetic and external preparation containing the same
JP2005002019A (en) Pimple-improving agent
JPS63297309A (en) Skin drug for external use

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090130

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090130

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 12

Free format text: PAYMENT UNTIL: 20100130

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110130

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110130

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120130

Year of fee payment: 14

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 14

Free format text: PAYMENT UNTIL: 20120130

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130130

Year of fee payment: 15

EXPY Cancellation because of completion of term